APA (7th ed.) Citation

Fernandes, J. M. S., Pagani, E., Wenceslau, C. V., Ynoue, L. H., Ferrara, L., & Kerkis, I. (2025). A phase I, open-label study of intravenous human dental pulp stem cells (NestaCell®) at two dose levels in patients with Huntington’s disease. Stem Cell Research & Therapy, 16(1), 1-11. https://doi.org/10.1186/s13287-025-04703-w

Chicago Style (17th ed.) Citation

Fernandes, Joyce Macedo Sanches, Eduardo Pagani, Cristiane Valverde Wenceslau, Leandro Hideki Ynoue, Luciana Ferrara, and Irina Kerkis. "A Phase I, Open-label Study of Intravenous Human Dental Pulp Stem Cells (NestaCell®) at Two Dose Levels in Patients with Huntington’s Disease." Stem Cell Research & Therapy 16, no. 1 (2025): 1-11. https://doi.org/10.1186/s13287-025-04703-w.

MLA (9th ed.) Citation

Fernandes, Joyce Macedo Sanches, et al. "A Phase I, Open-label Study of Intravenous Human Dental Pulp Stem Cells (NestaCell®) at Two Dose Levels in Patients with Huntington’s Disease." Stem Cell Research & Therapy, vol. 16, no. 1, 2025, pp. 1-11, https://doi.org/10.1186/s13287-025-04703-w.